EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation

M Chelsea Lane, Catherine J Luke, Joseph Bresee, Vivien G Dugan, Diane J Post, Julie Schafer, Paul C Roberts, David E Wentworth, Michael G Ison iD

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.13358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von M Chelsea Lane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On November 13–14, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) in partnership with the Task Force for Global Health, Flu Lab, the Canadian Institutes of Health Research, and the Centers for Disease Control and Prevention convened a meeting on controlled human influenza virus infection model (CHIVIM) studies to review the current research landscape of CHIVIM studies and to generate actionable next steps. Presentations and panel discussions highlighted CHIVIM use cases, regulatory and ethical considerations, innovations, networks and standardization, and the utility of using CHIVIM in vaccine development. This report summarizes the presentations, discussions, key takeaways, and future directions for innovations in CHIVIMs. Experts agreed that CHIVIM studies can be valuable for the study of influenza infection, immune response, and transmission. Furthermore, they may have utility in the development of vaccines and other medical countermeasures; however, the use of CHIVIMs to de‐risk clinical development of investigational vaccines should employ a cautious approach. Endpoints in CHIVIM studies should be tailored to the specific use case. CHIVIM studies can provide useful supporting data for vaccine licensure but are not required and do not obviate the need for the conduct of field efficacy trials. Future directions in this field include the continued expansion of capacity to conduct CHIVIM studies, development of a broad panel of challenge viruses and assay reagents and standards that can be shared, streamlining of manufacturing processes, the exploration of targeted delivery of virus to the lower respiratory tract, efforts to more closely replicate natural influenza disease in CHIVIM, alignment on a definition of breadth to facilitate development of more broadly protective/universal vaccine approaches, and continued collaboration between stakeholders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesHumansAnimalsVaccine DevelopmentUnited StatesNational Institute of Allergy and Infectious Diseases (U.S.)Orthomyxoviridae

Stichwörter der Autor:innen

controlled human infection model (CHIM)controlled human infection model (CHIVIM)influenza vaccinesinfluenza virus

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • The Task Force for Global Health, Decatur, Georgia, USA.
  • Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Flu Lab, Palo Alto, California, USA.

ORCID-Profile: Michael G Ison

Zitieren

APA

Lane, M. C., Luke, C. J., Bresee, J., Dugan, V. G., Post, D. J., Schafer, J., Roberts, P. C., Wentworth, D. E., & Ison, M. G. (2024). Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13358

Vancouver

Lane MC, Luke CJ, Bresee J, Dugan VG, Post DJ, Schafer J, et al. Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13358

BibTeX
@article{Lane2024,
  author = {Lane, M Chelsea and Luke, Catherine J and Bresee, Joseph and Dugan, Vivien G and Post, Diane J and Schafer, Julie and Roberts, Paul C and Wentworth, David E and Ison, Michael G},
  title = {Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.13358}
}
Kostenlos starten →